Blueprint Medicines (BPMC)
NASDAQ:BPMC
Holding BPMC?
Track your performance easily

Blueprint Medicines (BPMC) Financial Statements

534 Followers

Blueprint Medicines Financial Overview

Blueprint Medicines's market cap is currently ―. The company's EPS TTM is $-3.423; its P/E ratio is -26.10; Blueprint Medicines is scheduled to report earnings on October 24, 2024, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 138.16M$ 96.12M$ 71.96M$ 56.57M$ 39.88M
Gross Profit$ 130.56M$ 92.92M$ 71.70M$ 53.78M$ 56.48M
EBIT$ -49.89M$ 104.39M$ -123.46M$ -129.71M$ -128.61M
EBITDA$ -43.82M$ 109.20M$ -121.93M$ -124.53M$ -122.77M
Net Income Common Stockholders$ -49.99M$ 89.14M$ -110.92M$ -130.17M$ -132.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 763.60M$ 647.90M$ 710.64M$ 712.98M$ 722.63M
Total Assets$ 1.20B$ 1.04B$ 1.05B$ 1.11B$ 1.11B
Total Debt$ 740.35M$ 597.93M$ 774.12M$ 774.18M$ 675.68M
Net Debt$ -23.25M$ -49.97M$ 63.48M$ 61.19M$ -46.95M
Total Liabilities$ 883.32M$ 727.79M$ 918.64M$ 902.69M$ 795.32M
Stockholders Equity$ 320.24M$ 310.69M$ 130.61M$ 202.61M$ 311.13M
Cash Flow-
Free Cash Flow$ -50.64M$ -102.62M$ -83.60M$ -110.73M$ -133.03M
Operating Cash Flow$ -48.07M$ -101.51M$ -78.93M$ -104.48M$ -130.47M
Investing Cash Flow$ -188.29M$ 77.13M$ 78.77M$ -9.59M$ 32.07M
Financing Cash Flow$ 178.01M$ 66.96M$ 15.53M$ 98.40M$ 5.30M
Currency in USD

Blueprint Medicines Earnings and Revenue History

Blueprint Medicines Debt to Assets

Blueprint Medicines Cash Flow

Blueprint Medicines Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis